27. Louie S, Morrissey BM, Kenyon NJ, et al. The critically ill asthmatic--from ICU to discharge. Clin Rev Allergy Immunol, 2012, 43(1-2):30-44.
[2]
28. Schivo M, Phan C, Louie S, et al. Critical asthma syndrome in the ICU. Clin Rev Allergy Immunol, 2015, 48:31-44.
[3]
30. Rowe BH, Edmonds ML, Spooner CH, et al. Corticosteroid therapy for acute asthma. Respir Med, 2004, 98:275-284.
[4]
31. Schatz M, Dombrowski MP, Wise R, et al. Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol, 2003, 112:283-288.
[5]
32. Global strategy for asthma management and prevention.Global Initiative for Asthma (GINA). 2012. Available from:http://www.ginasthma.org[accessed 2014-01-17].
[6]
33. British Thoracic Society & Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. 2012, Available from:http://www.sign.ac.uk/pdf/sign101.pdf[accessed 2014-01-17].
[7]
34. McCallister JW, Benninger CG, Frey HA, et al. Pregnancy related treatment disparities of acute asthma exacerbations in the emergency department. Respir Med, 2011, 105:1434-1440.
[8]
35. Cossette B, Beauchesne MF, Forget A, et al. Systemic corticosteroids for the treatment of asthma exacerbations during and outside of pregnancy in an acute-care setting. Respir Med, 2014, 108:1260-1267.
[9]
36. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS results of a randomized controlled trial. 2007. Chest, 2009, 136(5 Suppl):e30.
[10]
37. Tang BM, Craig JC, Eslick GD, et al. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome:a systematic review and meta-analysis. Crit Care Med, 2009, 37:1594-1603.
[11]
38. Meduri GU, Bridges L, Shih MC, et al. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes:analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med, 2016, 42:829-840.
1. Kiser TH, Allen RR, Valuck RJ, et al. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2014, 189:1052-1064.
[14]
2. Haskell RJ, Wong BM, Hansen JE. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med, 1983, 143:1324-1327.
[15]
3. Rowe BH, Sevcik W, Villa-Roel C. Management of severe acute asthma in the emergency department. Curr Opin Crit Care, 2011, 17:335-341.
[16]
4. Umberto MG, Bell W, Sinclair S, et al. Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment. Presse Med, 2011, 40:543-560.
[17]
5. Lemiale V, Debrumetz A, Delannoy A, et al. Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia. Respir Res, 2013, 14:87.
[18]
6. Ranzani OT, Ferrer M, Esperatti M, et al. Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia. Crit Care Med, 2012, 40:2552-2561.
10. WHO:the Top 10 Causes of Death. 2013. Available from:http://www.who.int/mediacentre/factsheets/fs310/en/index.html.
[23]
11. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign:International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med, 2013, 39:165-228.
14. Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response:a randomized clinical trial. JAMA, 2015, 313:677-686.
[27]
18. Azoulay E, Mokart D, Rabbat A, et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure:prospective multicenter data. Crit Care Med, 2008. 36:100-107.
[28]
19. Bollée G, Sarfati C, Thiéry G, et al. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest, 2007, 132:1305-1310.
16. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults:a systematic review. JAMA, 2009, 301:2362-2375.
[31]
17. Magne D, Angoulvant A, Botterel F, et al. Pneumocystosis:a network survey in the Paris area 2003-2008. Eur J Clin Microbiol Infect Dis, 2011, 30:673-675.
[32]
20. Gagnon S, Boota AM, Fischl MA, et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome:a double-blind, placebo-controlled trial. N Engl J Med, 1990, 323:1444-1450.
[33]
21. Bozzette SA, Sattler FR, Chiu J, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med, 1990, 323:1451-1457.
[34]
22. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med, 2008, 359:2355-2365.
[35]
23. Walters JA, Tan DJ, White CJ, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2014:Cd001288.
[36]
24. Kiser TH, Vandivier RW. Severe acute exacerbations of chronic obstructive pulmonary disease:does the dosage of corticosteroids and type of antibiotic matter? Curr Opin Pulm Med, 2015, 21:142-148.
[37]
25. Sun WP, Yuan GX, Hu YJ, et al. Effect of low-dose glucocorticoid on corticosteroid insufficient patients with acute exacerbation of chronic obstructive pulmonary disease. World J Emerg Med, 2015, 6:34-39.
[38]
26. GINA. Global Strategy for Asthma Management and Prevention 2015. Available from:http://www.ginasthma.org/documents/4.
[39]
29. Krishnan JA, Davis SQ, Naureckas ET, et al. An umbrella review:corticosteroid therapy for adults with acute asthma. Am J Med, 2009, 122:977-991.
